1. Home
  2. ICLR vs PEN Comparison

ICLR vs PEN Comparison

Compare ICLR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$203.11

Market Cap

13.1B

Sector

Health Care

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

SELL

Current Price

$322.45

Market Cap

12.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ICLR
PEN
Founded
1990
2004
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
12.6B
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
ICLR
PEN
Price
$203.11
$322.45
Analyst Decision
Buy
Hold
Analyst Count
18
17
Target Price
$231.29
★ $362.54
AVG Volume (30 Days)
★ 1.1M
397.6K
Earning Date
10-27-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1155.56
EPS
N/A
★ 2.77
Revenue
N/A
★ $1,403,665,000.00
Revenue This Year
N/A
$14.38
Revenue Next Year
$4.60
$12.44
P/E Ratio
★ $12.91
$115.60
Revenue Growth
N/A
★ 17.50
52 Week Low
$66.57
$258.59
52 Week High
$219.04
$362.41

Technical Indicators

Market Signals
Indicator
ICLR
PEN
Relative Strength Index (RSI) 65.97 47.80
Support Level $157.92 $315.76
Resistance Level N/A $320.08
Average True Range (ATR) 9.22 2.49
MACD 3.10 -0.32
Stochastic Oscillator 70.69 39.76

Price Performance

Historical Comparison
ICLR
PEN

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: